High Prevalence of Peripheral Arterial Disease and Low Treatment Rates in Elderly Primary Care Patients with Diabetes

Abstract

Representative data on peripheral arterial disease (PAD) in community-based office practice are scarce while at the same time of high interest. Thus, we aimed to determine the prevalence of peripheral arterial disease (PAD), comorbidity of atherothrombotic manifestations, and treatment intensity among elderly diabetic patients in primary care.

In this monitored cross-sectional study, 344 general practitioners throughout Germany determined the ankle-brachial index (ABI) of 6880 consecutive, unselected patients aged 65 years or older with bilateral Doppler ultrasound measurements. PAD was defined according to the recent American Heart Association guidelines (using the higher of the 2 systolic ankle pressures: ABI < 0.9) or peripheral revascularisation, or amputation because of PAD. Coronary events (CAD) and cerebrovascular events (CVD) were taken from the patient's history without additional diagnostic measures. Diabetes was defined according to the clinical diagnosis of the physician and/or HbA1c ≥ 6.5 % and/or intake of oral antidiabetic medication and/or application of insulin.

1.743 patients were classified as diabetics: the median disease duration was 6 years (1st; 3rd quartile: 2; 11), median HbA1c 6.6 % (5.9; 7.3), mean age 72.5 ± 5.4 years, and 51.4 % were females. Diabetics had in comparison with non-diabetics a higher prevalence of PAD defined as ABI < 0.9 (26.3 % vs. 15.3 %, univariate odds ratio 2.0 [95 % confidence interval: 1.7; 2.3]), intermittent claudication (5.1 % vs. 2.1 %, OR: 2.5 [1.9; 3.4]), known CAD (16.1 % vs. 10.6 %, OR: 1.6 [1.4; 1.9]), and known CVD (6.8 % vs. 4.8 %; OR: 1.4 [1.2; 1.8]). 57.4 % of the diabetics with previously known PAD (as only atherothrombotic manifestation) received antiplatelet therapy (vs. 75.1 % with CAD and/or CVD only).

The ABI was suitable as screening measure in the primary care setting. In elderly diabetics in comparison to non-diabetics, the prevalence of PAD was very high. Despite the known benefits of antiplatelet therapy, PAD patients were less intensively treated than patients with CAD or CVD.

Key words

Peripheral arterial disease - diabetes - prevalence - atherosclerosis - coronary artery disease - cerebrovascular disease - cross sectional study

References

• 1 Abbott R, Rodriguez B, Petrovitch H, Yano K, Schatz I, Popper J, Masaki K, Ross G, Curb J. Ankle-brachial blood pressure in elderly men and the risk of stroke: the Honolulu Heart Program.  J Clin Epidemiol. 2001;  54 973-978
• 2 Adler A I, Stevens R J, Neil A, Stratton I M, Boulton A JM, Holman R R. UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes.  Diabetes Care. 2002;  25 894-899
• 3 Antithrombotic Trialists Collaboration . Collaborative meta-analysis of randomised trials of anti-platelet therapy for prevention of death, myocardial infarction and stroke in high-risk patients.  Brit Med J. 2002;  324 71-86
• 4 Arbeitsgruppe Epidemiologische Methoden der Deutschen Arbeitsgemeinschaft Epidemiologie (DAE) .Leitlinien und Empfehlungen zur Sicherung von Guter Epidemiologischer Praxis (GEP). DAE 2000
• 5 Bainton D, Sweetnam P, Baker I, Elwood P. Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell Prospective Heart Disease Study.  Br Heart J. 1994;  72 128-132
• 6 Belch J JF, Topol E J, Agnelli G, Bertrand M, Califf R M, Clement D L, Creager M A, Easton J D, Gavin I, James R, Greenland P, Hankey G, Hanrath P, Hirsch A T, Meyer J, Smith S C, Sullivan F, Weber M A. Critical issues in peripheral arterial disease detection and management: A call to action.  Arch Intern Med. 2003;  163 884-892
• 7 Bowlin S J, Medalie J H, Flocke S A, Zyzanski S J, Goldbourt U. Epidemiology of intermittent claudication in middle-aged men.  Am J Epidemiol. 1994;  140 418-430
• 8 Brand F N, Kannel W B, Evans J, Larson M G, Wolf P A. Glucose intolerance, physical signs of peripheral artery disease, and risk of cardiovascular events: the Framingham Study.  Am Heart J. 1998;  136 919-927
• 9 Curb J D, Masaki K, Rodriguez B L, Abbott R D, Burchfiel C M, Chen R, Petrovitch H, Sharp D, Yano K. Peripheral artery disease and cardiovascular risk factors in the elderly. The Honolulu Heart Program.  Arterioscler Thromb Vasc Biol. 1996;  16 1495-1500
• 10 Deedwania P. Diabetes and vascular disease: common links in the emerging epidemic of coronary artery disease.  Am J Cardiol. 2003;  91 68-71
• 11 Dolan N C, Liu K, Criqui M H, Greenland P, Guralnik J M, Chan C, Schneider J R, Mandapat A L, Martin G, McDermott M M. Peripheral artery disease, diabetes, and reduced lower extremity functioning.  Diabetes Care. 2002;  25 113-120
• 12 Dormandy J, Rutherford R. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC).  J Vasc Surg. 2000;  31 S1-S296
• 13 Gaede P, Vedel P, Larsen N, Jensen G VH, Parving H-H, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.  N Engl J Med. 2003;  348 383-393
• 14 getABI Study Group . The German Epidemiological Trial on Ankle Brachial Index (getABI): rationale, design and methods.  VASA. 2002;  31 241-248
• 15 Greenland P, Abrams J, Aurigemma G P, Bond M G, Clark L T, Criqui M H, Crouse 3rd J R, Friedman L, Fuster V, Herrington D M, Kuller L H, Ridker P M, Roberts W C, Stanford W, Stone N, Swan H J, Taubert K A, Wexler L. Prevention Conference V. Beyond secondary prevention: Identifying the high-risk patient for primary prevention. Noninvasive tests of atherosclerotic burden.  Circulation. 2000;  101 E16-22
• 16 Hirsch A T, Criqui M H, Treat-Jacobson D, Regensteiner J G, Creager M A, Olin J W, Krook S H, Hunninghake D B, Comerota A J, Walsh M E, McDermott M M, Hiatt W R. Peripheral arterial disease detection, awareness, and treatment in primary care.  JAMA. 2001;  286 1317-1324
• 17 Kallio M, Forsblom C, Groop P-H, Groop L, Lepantalo M. Development of new peripheral arterial occlusive disease in patients with type 2 diabetes during a mean follow-up of 11 years.  Diabetes Care. 2003;  26 1241-1245
• 18 Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes.  Diabetes. 1999;  48 937-942
• 19 Leng G C, Lee A J, Fowkes F G, Whiteman M, Dunbar J, Housley E, Ruckley C V. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population.  Int J Epidemiol. 1996;  25 1172-1181
• 20 MacGregor A S, Price J F, Hau C M, Lee A J, Carson M N, Fowkes F G. Role of systolic blood pressure and plasma triglycerides in diabetic peripheral arterial disease. The Edinburgh Artery Study.  Diabetes Care. 1999;  22 453-458
• 21 Mackaay A J, Beks P J, Dur A H, Bischoff M, Scholma J, Heine R J, Rauwerda J A. The distribution of peripheral vascular disease in a Dutch Caucasian population: comparison of type II diabetic and non-diabetic subjects.  Eur J Vasc Endovasc Surg. 1995;  9 170-175
• 22 McDermott M M, Greenland P, Liu K, Guralnik J M, Celic L, Criqui M H, Chan C, Martin G J, Schneider J, Pearce W H, Taylor L M, Clark E. The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study.  Ann Intern Med. 2002;  136 873-883
• 23 McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality.  Atherosclerosis. 1991;  87 119-128
• 24 Meijer W T, Hoes A W, Rutgers D, Bots M L, Hofman A, Grobbee D E. Peripheral arterial disease in the elderly: The Rotterdam Study.  Arterioscler Thromb Vasc Biol. 1998;  18 185-192
• 25 Murabito J M, Evans J C, Nieto K, Larson M G, Levy D, Wilson P WF. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study.  American Heart Journal. 2002;  143 961-965
• 26 Ness J, Aronow W S, Ahn C. Risk factors for symptomatic peripheral arterial disease in older persons in an academic hospital-based geriatrics practice.  J Am Geriatr Soc. 2000;  48 312-314
• 27 Newman A B, Siscovick D S, Manolio T A, Polak J, Fried L P, Borhani N O, Wolfson S K. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group.  Circulation. 1993;  88 837-845
• 28 Newman A B, Shemanski L, Manolio T A, Cushman M, Mittelmark M, Polak J F, Powe N R, Siscovick D. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group.  Arterioscler Thromb Vasc Biol. 1999;  19 538-545
• 29 Orchard T J, Strandness Jr D E. Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association September 18 - 20, 1992 New Orleans, Louisiana.  Circulation. 1993;  88 819-828
• 30 Papamichael C M, Lekakis J P, Stamatelopoulos K S, Papaioannou T G, Alevizaki M K, Cimponeriu A T, Kanakakis J E, Papapanagiotou A, Kalofoutis A T, Stamatelopoulos S F. Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease.  Am J Cardiol. 2000;  86 615-618
• 31 Rose G. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys.  Bull World Health Organ. 1962;  27 645-658
• 32 Schmieder F A, Comerota A J. Intermittent claudication: magnitude of the problem, patient evaluation, and therapeutic strategies.  Am J Cardiol. 2001;  87 3D-13D
• 33 Tsai A W, Folsom A R, Rosamond W D, Jones D W. Ankle-brachial index and 7-year ischemic stroke incidence: The ARIC study.  Stroke. 2001;  32 1721-1724
• 34 Turner R, Cull C, Holman R. United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.  Ann Intern Med. 1996;  124 136-145
• 35 UK Prospective Diabetes Study Group . Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38.  BMJ. 1998;  317 703-713
• 36 Walters D P, Gatling W, Mullee M A, Hill R D. The prevalence, detection, and epidemiological correlates of peripheral vascular disease: a comparison of diabetic and non-diabetic subjects in an English community.  Diabet Med. 1992;  9 710-715
• 37 Zander E, Heinke P, Reindel J, Kohnert K D, Kairies U, Braun J, Eckel L, Kerner W. Peripheral arterial disease in diabetes mellitus type 1 and type 2: are there different risk factors?.  VASA. 2002;  31 249-254
• 38 Zheng Z J, Sharrett A R, Chambless L E, Rosamond W D, Nieto F J, Sheps D S, Dobs A, Evans G W, Heiss G. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study.  Atherosclerosis. 1997;  131 115-125